Qanatpharma AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Lumacaftor Yields Reversal of Impaired Cerebral Blood Flow in Heart Failure Patients (NCT07695090) | Qanatpharma AG | 2026-07-01 |
Track Qanatpharma AG automatically
Every clearance here is in the API, with alerts when new ones post.